Page last updated: 2024-08-23

n-(2-hydroxypropyl)methacrylamide and Angiogenesis, Pathologic

n-(2-hydroxypropyl)methacrylamide has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
David, A; Feinshtein, V; Zaiden, M1
Hovorka, O; Pechar, M; Pola, R; Ríhová, B; Studenovský, M; Ulbrich, K; Vetvicka, D1

Other Studies

2 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Angiogenesis, Pathologic

ArticleYear
Inhibition of CD44v3 and CD44v6 function blocks tumor invasion and metastatic colonization.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, 07-10, Volume: 257

    Topics: Acrylamides; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Drug Delivery Systems; Female; Humans; Hyaluronan Receptors; Male; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptides; Prostatic Neoplasms; Tissue Distribution

2017
HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides.
    Journal of drug targeting, 2009, Volume: 17, Issue:10

    Topics: Acrylamides; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Drug Delivery Systems; Endothelium, Vascular; Humans; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Time Factors

2009